Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Evolving business
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Comment by Clongobongoon Jan 10, 2025 10:28am
36 Views
Post# 36397828

RE:RE:RE:RE:RE:RE:Evolving business

RE:RE:RE:RE:RE:RE:Evolving business
The adressable market for medipharm is close or near that 200M as Brazilian pharmacy market is mostly composed of tinctures. There is limited flower from information I gathered.

Also, the way medipharms revenue will evolve in that market is 100% dependent on Teutos strategy (look towards STADA for previous experience with pharma). Given Teuto is a low cost/ affordable drug provider, I would assume they need volume to make those margins make sense business wise.

As Brazil mj market is in a high growth phase, Teuto has a decent distribution network, there is limited competition from flower and tinctures have longer shelf life than flower, this could be an opportunity to take a stance and really fill up shelves.

I agree there is alot of uncertainty and ups and downs to come while they dial in demand.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities